The Emerging Role of Molecular Testing in an Era of Precision Medicine - Non–Small Cell Lung Cancer
An online panel discussion with leading experts knowledgeable about the importance of utilizing molecular testing in the diagnosis of cancer patients, including Issues and perspectives from various stakeholders on molecular testing and next-generation sequencing. The education will also include individual patient-focused cases, which will give clinicians in oncology an opportunity to put into practice what they have learned and to further enhance their subject matter understanding, as well as to allow them to interact directly with clinical content experts.
This activity is supported by an educational grant from AstraZeneca
These CME/CE/CPE certified activities are jointly provided by